Bell Rock Capital’s Elevance Health ELV Stock Holding History

Bell Rock Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3	Closed	–	–	397
2019 Q1	$0	Hold	3	–	–	﹤0.01%	426
2018 Q4	$0	Buy	+3	New	+$825	﹤0.01%	436

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bell Rock Capital's ELV Position: Q2 2019 in Review

Bell Rock Capital sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 3 shares.

Bell Rock Capital first reported a position in ELV in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

Bell Rock Capital reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
Bell Rock Capital sold 3 Elevance Health shares in Q2 2019.
Bell Rock Capital first reported a position in Elevance Health in Q4 2018 and held it in 2 quarters.
Bell Rock Capital's Elevance Health position peaked at $0 in Q1 2019.
1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Bell Rock Capital's 13F filing for Q2 2019, filed 31 Jul 2019.